March 19, 2009 - The FDA has approved an investigational device exemption (IDE) for a multicenter clinical trial ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
March 19, 2009
March 17, 2009 – Twelve-month data from the ATLANTA Trial shows that the CATANIA Coronary Stent System with ...
March 17, 2009
March 16, 2009 - Cordis Corp. said today it plans to launch a global, head-to-head, randomized clinical trial ...
March 16, 2009Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
March 13, 2009 - A comprehensive analysis published this week in The Lancet from the ABSORB clinical trial ...
March 13, 2009
March 13, 2009 -Medical device pioneer Stentys said today it extended its self-expanding and disconnectable ...
March 13, 2009
March 12, 2009 - CeloNova BioSciences Inc. said yesterday physicians performing a live stent implantation during ...
March 12, 2009March 10, 2009 - Carotid artery stenting (CAS) has demonstrated outcomes consistent with the American Heart ...
March 10, 2009
March 5, 2009 - In the first six-year follow-up of a pivotal study of any drug-eluting stent, the clinical ...
March 05, 2009
March 5, 2009 - Prescient Medical Inc. announced it completed enrollment in February of 30 patients in the first ...
March 05, 2009
March 3, 2009 - Boston Scientific Corp. today said it launched its TAXUS Liberté Paclitaxel-Eluting Coronary Stent ...
March 03, 2009
February 19, 2009 - The New England Journal of Medicine this week published the results from the SYNTAX trial, in ...
February 19, 2009
February 16 - The CYPHER SELECT Plus Sirolimus-eluting Coronary Stent has received CE marking within the European ...
February 16, 2009
February 11, 2009 – On Wednesday, Feb. 18, 2009 at 6:30 pm, Shawnee Mission Medical Center (SMMC), Merriam, KS ...
February 11, 2009
Abbott Vascular's XIENCE V Everolimus-Eluting Coronary is indicated for improving coronary luminal diameter in ...
February 10, 2009
February 10, 2009 - W. L. Gore and Associates today said at the International Congress on Endovascular ...
February 10, 2009